References: |
1. Sithanandam, G.; Latif, F.; Duh, F-M.; Bernal, R.; Smola, U.; Li, H.; Kuzmin, I.; Wixler, V.; Geil, L.; Shrestha, S.; Lloyd, P.; Bader, S.; Sekido, Y.; Tartof, K.D.; Kashuba, V.I.; Zabarovsky, E.R.; Dean, M.; Klein, G.; Lerman, M.I.; Minna, J.D.; Rapp, U.R.; Allikmets, R.: 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region. Molec. Cell. Biol. 16: 868-876, 1996. 2. Ludwig, S.; Engel, K.; Hoffmeyer, A.; Sithanandam, G.; Neufeld, B.; Palm, D.; Gaestel, M.; Rapp, U.: 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Molec. Cell. Biol. 16: 6687-6697, 1996. 3. Neufeld B, Grosse-Wilde A, Hoffmeyer A, Jordan BW, Chen P, Dinev D, Ludwig S, Rapp UR. Serine/Threonine kinases 3pK and MAPK-activated protein kinase 2 interact with the basic helix-loop- helix transcription factor E47 and repress its transcriptional activity.J Biol Chem. 2000 Jul 7; 275(27):20239-42. 4. Maizels, E. T.; Mukherjee, A.; Sithanandam, G.; Peters, C. A.; Cottom, J.; Mayo, K. E.; Hunzicker- Dunn, M.: Developmental regulation of mitogen-activated protein kinase-activated kinases-2 and -3 (MAPKAPK-2/-3) in vivo during corpus luteum formation in the rat. Molec. Endocr. 15: 716-733, 2001. |